Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Leukemia, Myeloid, Acute 67Leukemia 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Lymphoma 20Lymphoma, Follicular 14Congenital Abnormalities 14Lymphoma, Non-Hodgkin 13Recurrence 12Lymphoma, Large B-Cell, Diffuse 12Leukemia, Monocytic, Acute 12Myelodysplastic Syndromes 11Leukemia, Lymphocytic, Chronic, B-Cell 9Leukemia, Erythroblastic, Acute 9Prostatic Neoplasms 8Lymphoma, Large-Cell, Immunoblastic 8Leukemia, Myelomonocytic, Acute 8Leukemia, Megakaryoblastic, Acute 8Leukemia, Biphenotypic, Acute 8Lymphoma, Mantle-Cell 7Hodgkin Disease 5Burkitt Lymphoma 5Blast Crisis 5Lymphoma, B-Cell, Marginal Zone 3Leukemia, Promyelocytic, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Sarcoma, Myeloid 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2

Interventions

Radiosurgery 79Capecitabine 77Oxaliplatin 74Fluorouracil 69Bevacizumab 69Gemcitabine 67Leucovorin 61pembrolizumab 53Nivolumab 53Paclitaxel 48Irinotecan 47Radiotherapy 45Cisplatin 44Everolimus 38Magnetic Resonance Spectroscopy 36Drug Therapy 36Docetaxel 36Cyclophosphamide 35Cetuximab 35Ipilimumab 32Carboplatin 32Trastuzumab 31Sunitinib 30Sorafenib 26Erlotinib Hydrochloride 25Doxorubicin 23Surveys and Questionnaires 20Surgical Procedures, Operative 20Specimen Handling 20Biopsy 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasm Metastasis × Mitoxantrone × Clear all
NCT01594918 2017-07-21

Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer

University of California, San Francisco

Phase 1 Completed
25 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡